Skip to main content

Table 1 Comparative analysis of the variables before and after treatment, independent of genotype

From: Positive association of the hepatic lipase gene polymorphism c.514C > T with estrogen replacement therapy response

Groups N Mean (mg/dL) Standard deviation t p
TotalChol 58 210.31 45.47 0.14 0.89
TotalChol2 58 209.41 43.19   
HDL-C 58 58.95 13.45 0.94 0.35
HDL-C2 58 57.76 14.44   
LDL-C 58 120.052 38.71 -0.83 0.41
LDL-C2 58 125.52 38.08   
TG 58 138.07 65.40 2.16 0.03
TG2 58 122.07 66.50   
  1. TotalChol: total pre-treatment cholesterol; HDL-C: pre-treatment high-density lipoprotein cholesterol; LDL-C: pre-treatment low-density lipoprotein cholesterol; TG: pre-treatment triglycerides; TotalChol2: total post-treatment cholesterol; HDL-C2: post-treatment high-density lipoprotein cholesterol; LDL-C2: post-treatment low-density lipoprotein cholesterol; TG2: post-treatment triglycerides.